source
- Gan & Lee reports positive Phase 3 obesity trial results; J&J shares multiple myeloma dataGan & Lee Pharmaceuticals, a China‑based insulin specialist, announced topline results from its Phase 3 obesity trial, indicating a successful outcome. The company said the study met its primary e…
- Neumora Therapeutics halts lead depression drug after two more Phase 3 failures, plans 35% staff cutsNeumora Therapeutics announced that its lead depression candidate will be discontinued after it did not meet primary endpoints in two additional Phase 3 trials. The company said the data were consi…